Cleary Gottlieb Steen & Hamilton‘s integrated US and Hong Kong capital markets team has a strong reputation advising PRC/Hong Kong issuers as well as international sponsors/underwriters on listings and secondary offerings in Hong Kong. A number of these have recently taken the form of dual primary listings by introduction, including on behalf of OneConnect Financial Technology Co where as well as its listing on the HKSE its ADSs are listed on the NYSE. New York and Hong Kong-qualified partner Shuang Zhao is one of the key practitioners advising on domestic and international SEC-registered and Reg S/Rule144A IPOs. UK and Hong Kong-qualified partner Freeman Chan is also a key practitioner both for conventional ECM work, as well as public M&A, where he is able to leverage his role as chairman of the Takeovers and Mergers Panel. Miao Zhang, who was recently promoted to partner, co-heads the team alongside Zhao and Chan.
Testimonials
Collated independently by Legal 500 research team.
- 'They understand how to balance between being commercial / efficient and being thorough / thoughtful in supporting sophisticated clients achieve their transaction objectives.'
Key clients
- B of A Securities
- Burning Rock Biotech
Work highlights
- Advised Goldman Sachs and CSCI, as joint sponsors, and Goldman Sachs, CSCI, and CICC, as the overall co-ordinators, joint global coordinators, joint bookrunners, and joint lead managers, in the HK$5.3bn global offering of ordinary shares and primary listing of ZJLD Group Inc. on the Main Board of the Hong Kong Stock Exchange.
- Advised Burning Rock Biotech in its direct listing on the London Stock Exchange.